insights_auto
Why is 0QF down 5.87%?
Dive Deeperchevron_right
0QF:ETR
Moderna Inc
€165.12
arrow_downward
-5.87%(-10.30) 1D
Sep 30, 5:35:43 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0QF...
Open
€180.86
High
€182.00
Low
€163.62
Mkt. cap
74.73B
Avg. vol.
44.42K
Volume
52.72K
52-wk high
€184.20
52-wk low
€19.37
No. of employees
5K
Open
€180.86
High
€182.00
Low
€163.62
Mkt. cap
74.73B
Avg. vol.
44.42K
Volume
52.72K
52-wk high
€184.20
52-wk low
€19.37
No. of employees
5K
News stories
From web sources and news partners
Zacks Investment Research
·
10 minutes ago
Moderna vs. BioNTech: Which mRNA Stock Is the Better Buy Now?
Bloomberg.com
·
47 minutes ago
Moderna Tumbles as Citi Advises Selling Following 600% Rally
TradingView
·
1 hour ago
Why Moderna (MRNA) Shares Are Falling Today
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In 2026, Time ranked Moderna as number one in their World's Most Impactful Companies list. Wikipedia
About Moderna Inc